Lou Libby, M.D., a pulmonary critical care physician and Chief Medical Officer of The Oregon Clinic, will receive the 2011 Breathing for Life Award from the American Thoracic Society (ATS) Foundation at the Third Annual ATS Foundation Research Program Dinner to be held in Denver on Saturday, May 14, 2011. This is the highest honor that the Foundation can give to an ATS leader.
Dr. Libby was selected from several international candidates for his longstanding role in inspiring and encouraging ATS members and others to support the Foundation’s charitable-giving mission, which plays a vital role in funding research relating to pulmonary, critical care and sleep medicine. He has served as Chair of the ATS Clinicians Advisory Committee from 2007 to the present.
In addition to the Breathing for Life Award, Dr. Libby has received numerous other awards and accolades, including the Mission Medal Award from Providence Portland Medical Center (2002) and the Outstanding Clinician Award from ATS (2007). The Portland Monthly magazine has highlighted Dr. Libby in its annual list of Top Doctors since its inception (2004-2011).
Dr. Libby is the third recipient to receive this prestigious honor. Nominees must demonstrate support for the specialties of respiratory, critical care and sleep medicine by raising awareness of the burden of diseases within these specialties and encouraging philanthropy from ATS members, non-ATS members and the public-at-large. Additionally, nominees must play an active philanthropic role within their own communities. Last year’s Breathing for Life Award was given to U.S. Senator Mike Crapo of Idaho, the co-chair of the Congressional COPD (Chronic Obstructive Pulmonary Disease) Caucus.
“In addition to his outstanding skills as a physician, Dr. Libby is an inspiring colleague in many areas, including advocacy, patient care and giving back to the community,” said Craig Fausel, M.D., president and gastroenterologist at The Oregon Clinic. “We all congratulate him on this well-deserved award.”
The ATS Foundation was established in 2004 to raise funds for the ATS Foundation Research Program, which plays a critical role in ATS’s mission of preventing and treating respiratory disease through research, education, patient care and advocacy. The Foundation depends on the financial support of individuals, corporations and foundations for its success. Among the Foundation Trustees are scientists, clinicians, and representatives of industry and patient advocacy organizations.